APO RESEARCH · REPORT
Stable Isotope Labeled Biomolecules
This report studies the Stable Isotope Labeled Biomolecules market, Stable Isotope Labeled Biomolecules refer to the biomolecule which is labeled by replacing specific atoms by their isotope, and then the reactant is then allowed to undergo the reaction.
Product & engineering
Understand the product.
This report studies the Stable Isotope Labeled Biomolecules market, Stable Isotope Labeled Biomolecules refer to the biomolecule which is labeled by replacing specific atoms by their isotope, and then the reactant is then allowed to undergo the reaction.
An important tool for high-resolution structure determination for NMR spectroscopy is the use of stable isotopically labeled biomolecules. By either selectively or uniformly incorporating stable isotopes into proteins, the user is able to significantly reduce the complexity of their spectra. D Labeled Biomolecules, 15N, and deuterium are the most common isotopes incorporated into proteins. Microbial expression systems, cell-free extracts, peptide synthesis and custom synthesis provide a variety of options for accomplishing the incorporation of the labels. Microbial expression systems are cell-based protein expression systems in which the microbes are grown in either a defined or complex media with D Labeled Biomolecules labeled glucoses and 15N Labeled Biomoleculeslabeled ammonium salts as the sole sources of carbon and nitrogen respectively. Ease of use, adaptability and high protein yields have made these expression systems the most popular technique for stable isotope incorporation. Cell-free extracts and custom synthesis also present their own individual advantages with the use of uniformly or selectively labeled amino acids. Cell-free extracts allow the user to more readily implement high-throughput in vitro protein expression as many proteins are difficult to express in vivo due to complications such as toxicity. Custom synthesis allows for unique, site-specific incorporation of isotopes into peptides allowing the user to study distinct structural regions.
Selected research
Industry Research
Stable Isotope Labeled Biomolecules Industry Research Report 2026
Market perspective
This report studies the Stable Isotope Labeled Biomolecules market, Stable Isotope Labeled Biomolecules refer to the biomolecule which is labeled by replacing specific atoms by their isotope, and then the reactant is then allowed to undergo the reaction.
An important tool for high-resolution structure determination for NMR spectroscopy is the use of stable isotopically labeled biomolecules. By either selectively or uniformly incorporating stable isotopes into proteins, the user is able to significantly reduce the complexity of their spectra. D Labeled Biomolecules, 15N, and deuterium are the most common isotopes incorporated into proteins. Microbial expression systems, cell-free extracts, peptide synthesis and custom synthesis provide a variety of options for accomplishing the incorporation of the labels. Microbial expression systems are cell-based protein expression systems in which the microbes are grown in either a defined or complex media with D Labeled Biomolecules labeled glucoses and 15N Labeled Biomoleculeslabeled ammonium salts as the sole sources of carbon and nitrogen respectively. Ease of use, adaptability and high protein yields have made these expression systems the most popular technique for stable isotope incorporation. Cell-free extracts and custom synthesis also present their own individual advantages with the use of uniformly or selectively labeled amino acids. Cell-free extracts allow the user to more readily implement high-throughput in vitro protein expression as many proteins are difficult to express in vivo due to complications such as toxicity. Custom synthesis allows for unique, site-specific incorporation of isotopes into peptides allowing the user to study distinct structural regions.
The major players in global Stable Isotope Labeled Biomolecules market include Cambridge Isotope Laboratories, Sigma-Aldrich, Thermo Fisher Scientific, etc. The top 3 players occupy about 50% shares of the global market. North America and Europe are main markets, they occupy about 90% of the global market. 13C Labeled Biomolecules is the main type, with a share about 50%. Medical is the main application, which holds a share about 50%.
Read the full market overview
Report Scope
This report quantifies the global Stable Isotope Labeled Biomolecules market in terms of revenue (US$ million) and, where applicable, sales volume (g), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/g) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Stable Isotope Labeled Biomolecules Market by Company
Cambridge Isotope Laboratories
Sigma-Aldrich
Thermo Fisher Scientific
LGC Standards
Toronto Research Chemicals
IsoLife
WITEGA Laboratorien
Omicron Biochemicals
Icon Isotopes
Medical Isotopes
Stable Isotope Labeled Biomolecules Segment by Type
D Labeled Biomolecules
15N Labeled Biomolecules
13C Labeled Biomolecules
Others
Stable Isotope Labeled Biomolecules Segment by Application
Scientific Research
Medical
Industrial
Others
Stable Isotope Labeled Biomolecules Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stable Isotope Labeled Biomolecules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Stable Isotope Labeled Biomolecules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stable Isotope Labeled Biomolecules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Stable Isotope Labeled Biomolecules manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Stable Isotope Labeled Biomolecules by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Stable Isotope Labeled Biomolecules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- D Labeled Biomolecules
- 15N Labeled Biomolecules
- 13C Labeled Biomolecules
- Others
Applications
- Scientific Research
- Medical
- Industrial
- Others
Companies covered
- Cambridge Isotope Laboratories
- Sigma-Aldrich
- Thermo Fisher Scientific
- LGC Standards
- Toronto Research Chemicals
- IsoLife
- WITEGA Laboratorien
- Omicron Biochemicals
- Icon Isotopes
- Medical Isotopes
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Stable Isotope Labeled Biomolecules Market Size (2021-2032)
- 2.2.2 Global Stable Isotope Labeled Biomolecules Sales (2021-2032)
- 2.2.3 Global Stable Isotope Labeled Biomolecules Market Average Price (2021-2032)
- 2.3 Stable Isotope Labeled Biomolecules by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 D Labeled Biomolecules
- 2.3.3 15N Labeled Biomolecules
- 2.3.4 13C Labeled Biomolecules
- 2.3.5 Others
- 2.4 Stable Isotope Labeled Biomolecules by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Scientific Research
- 2.4.3 Medical
- 2.4.4 Industrial
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Stable Isotope Labeled Biomolecules Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Stable Isotope Labeled Biomolecules Sales (g) of Manufacturers (2021-2026)
- 3.3 Global Stable Isotope Labeled Biomolecules Revenue of Manufacturers (2021-2026)
- 3.4 Global Stable Isotope Labeled Biomolecules Average Price by Manufacturers (2021-2026)
- 3.5 Global Stable Isotope Labeled Biomolecules Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Stable Isotope Labeled Biomolecules, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Stable Isotope Labeled Biomolecules, Product Type & Application
- 3.8 Global Manufacturers of Stable Isotope Labeled Biomolecules, Established Date
- 3.9 Global Stable Isotope Labeled Biomolecules Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Cambridge Isotope Laboratories
- 4.1.1 Cambridge Isotope Laboratories Company Information
- 4.1.2 Cambridge Isotope Laboratories Business Overview
- 4.1.3 Cambridge Isotope Laboratories Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Cambridge Isotope Laboratories Stable Isotope Labeled Biomolecules Product Portfolio
- 4.1.5 Cambridge Isotope Laboratories Recent Developments
- 4.2 Sigma-Aldrich
- 4.2.1 Sigma-Aldrich Company Information
- 4.2.2 Sigma-Aldrich Business Overview
- 4.2.3 Sigma-Aldrich Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sigma-Aldrich Stable Isotope Labeled Biomolecules Product Portfolio
- 4.2.5 Sigma-Aldrich Recent Developments
- 4.3 Thermo Fisher Scientific
- 4.3.1 Thermo Fisher Scientific Company Information
- 4.3.2 Thermo Fisher Scientific Business Overview
- 4.3.3 Thermo Fisher Scientific Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Thermo Fisher Scientific Stable Isotope Labeled Biomolecules Product Portfolio
- 4.3.5 Thermo Fisher Scientific Recent Developments
- 4.4 LGC Standards
- 4.4.1 LGC Standards Company Information
- 4.4.2 LGC Standards Business Overview
- 4.4.3 LGC Standards Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 LGC Standards Stable Isotope Labeled Biomolecules Product Portfolio
- 4.4.5 LGC Standards Recent Developments
- 4.5 Toronto Research Chemicals
- 4.5.1 Toronto Research Chemicals Company Information
- 4.5.2 Toronto Research Chemicals Business Overview
- 4.5.3 Toronto Research Chemicals Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Toronto Research Chemicals Stable Isotope Labeled Biomolecules Product Portfolio
- 4.5.5 Toronto Research Chemicals Recent Developments
- 4.6 IsoLife
- 4.6.1 IsoLife Company Information
- 4.6.2 IsoLife Business Overview
- 4.6.3 IsoLife Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 IsoLife Stable Isotope Labeled Biomolecules Product Portfolio
- 4.6.5 IsoLife Recent Developments
- 4.7 WITEGA Laboratorien
- 4.7.1 WITEGA Laboratorien Company Information
- 4.7.2 WITEGA Laboratorien Business Overview
- 4.7.3 WITEGA Laboratorien Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 WITEGA Laboratorien Stable Isotope Labeled Biomolecules Product Portfolio
- 4.7.5 WITEGA Laboratorien Recent Developments
- 4.8 Omicron Biochemicals
- 4.8.1 Omicron Biochemicals Company Information
- 4.8.2 Omicron Biochemicals Business Overview
- 4.8.3 Omicron Biochemicals Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Omicron Biochemicals Stable Isotope Labeled Biomolecules Product Portfolio
- 4.8.5 Omicron Biochemicals Recent Developments
- 4.9 Icon Isotopes
- 4.9.1 Icon Isotopes Company Information
- 4.9.2 Icon Isotopes Business Overview
- 4.9.3 Icon Isotopes Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Icon Isotopes Stable Isotope Labeled Biomolecules Product Portfolio
- 4.9.5 Icon Isotopes Recent Developments
- 4.10 Medical Isotopes
- 4.10.1 Medical Isotopes Company Information
- 4.10.2 Medical Isotopes Business Overview
- 4.10.3 Medical Isotopes Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Medical Isotopes Stable Isotope Labeled Biomolecules Product Portfolio
- 4.10.5 Medical Isotopes Recent Developments
5 Global Stable Isotope Labeled Biomolecules Market Scenario by Region
- 5.1 Global Stable Isotope Labeled Biomolecules Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Stable Isotope Labeled Biomolecules Sales by Region: 2021-2032
- 5.2.1 Global Stable Isotope Labeled Biomolecules Sales by Region: 2021-2026
- 5.2.2 Global Stable Isotope Labeled Biomolecules Sales by Region: 2027-2032
- 5.3 Global Stable Isotope Labeled Biomolecules Revenue by Region: 2021-2032
- 5.3.1 Global Stable Isotope Labeled Biomolecules Revenue by Region: 2021-2026
- 5.3.2 Global Stable Isotope Labeled Biomolecules Revenue by Region: 2027-2032
- 5.4 North America Stable Isotope Labeled Biomolecules Market Facts & Figures by Country
- 5.4.1 North America Stable Isotope Labeled Biomolecules Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Stable Isotope Labeled Biomolecules Sales by Country (2021-2032)
- 5.4.3 North America Stable Isotope Labeled Biomolecules Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Stable Isotope Labeled Biomolecules Market Facts & Figures by Country
- 5.5.1 Europe Stable Isotope Labeled Biomolecules Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Stable Isotope Labeled Biomolecules Sales by Country (2021-2032)
- 5.5.3 Europe Stable Isotope Labeled Biomolecules Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Stable Isotope Labeled Biomolecules Market Facts & Figures by Country
- 5.6.1 Asia Pacific Stable Isotope Labeled Biomolecules Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Stable Isotope Labeled Biomolecules Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Stable Isotope Labeled Biomolecules Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Stable Isotope Labeled Biomolecules Market Facts & Figures by Country
- 5.7.1 South America Stable Isotope Labeled Biomolecules Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Stable Isotope Labeled Biomolecules Sales by Country (2021-2032)
- 5.7.3 South America Stable Isotope Labeled Biomolecules Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Stable Isotope Labeled Biomolecules Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Stable Isotope Labeled Biomolecules Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Stable Isotope Labeled Biomolecules Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Stable Isotope Labeled Biomolecules Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Stable Isotope Labeled Biomolecules Sales by Type (2021-2032)
- 6.1.1 Global Stable Isotope Labeled Biomolecules Sales by Type (2021-2032) & (g)
- 6.1.2 Global Stable Isotope Labeled Biomolecules Sales Market Share by Type (2021-2032)
- 6.2 Global Stable Isotope Labeled Biomolecules Revenue by Type (2021-2032)
- 6.2.1 Global Stable Isotope Labeled Biomolecules Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Stable Isotope Labeled Biomolecules Revenue Market Share by Type (2021-2032)
- 6.3 Global Stable Isotope Labeled Biomolecules Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Stable Isotope Labeled Biomolecules Sales by Application (2021-2032)
- 7.1.1 Global Stable Isotope Labeled Biomolecules Sales by Application (2021-2032) & (g)
- 7.1.2 Global Stable Isotope Labeled Biomolecules Sales Market Share by Application (2021-2032)
- 7.2 Global Stable Isotope Labeled Biomolecules Revenue by Application (2021-2032)
- 7.2.1 Global Stable Isotope Labeled Biomolecules Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Stable Isotope Labeled Biomolecules Revenue Market Share by Application (2021-2032)
- 7.3 Global Stable Isotope Labeled Biomolecules Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Stable Isotope Labeled Biomolecules Value Chain Analysis
- 8.1.1 Stable Isotope Labeled Biomolecules Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Stable Isotope Labeled Biomolecules Production Mode & Process
- 8.2 Stable Isotope Labeled Biomolecules Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Stable Isotope Labeled Biomolecules Distributors
- 8.2.3 Stable Isotope Labeled Biomolecules Customers
9 Global Stable Isotope Labeled Biomolecules Analyzing Market Dynamics
- 9.1 Stable Isotope Labeled Biomolecules Industry Trends
- 9.2 Stable Isotope Labeled Biomolecules Industry Drivers
- 9.3 Stable Isotope Labeled Biomolecules Industry Opportunities and Challenges
- 9.4 Stable Isotope Labeled Biomolecules Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst